TABLE 3.
Duration of Treatment, by Age Category
| Age Category | Estimatea | Hazard Ratio (Lower CI-Upper CI) | P |
|---|---|---|---|
|
| |||
| Duration of ECMO (unadjusted model) | |||
| Group 2 (50–64) | −0.18 | 0.83 (0.71–0.98) | 0.025 |
| Group 3 (65–74) | −0.13 | 0.88 (0.73–1.06) | 0.179 |
| Group 4 (≥ 75) | 0.01 | 1.01 (0.82–1.30) | 0.914 |
|
| |||
| Duration of ECMO (adjusted model) | |||
| Group 2 (50–64) | −0.17 | 0.84 (0.72–0.99) | 0.036 |
| Group 3 (65–74) | −0.12 | 0.89 (0.73–1.07) | 0.207 |
| Group 4 (≥ 75) | −0.01 | 0.99 (0.80–1.23) | 0.951 |
|
| |||
| Hospital length of stay (unadjusted) | |||
| Group 2 (50–64) | −0.18 | 0.83 (0.71–0.98) | 0.028 |
| Group 2 (65–74) | −0.03 | 0.97 (0.80–1.17) | 0.745 |
| Group 4 (≥ 75) | −0.07 | 0.93 (0.75–1.15) | 0.503 |
|
| |||
| Hospital length of stay (adjusted) | |||
| Group 2 (50–64) | −0.15 | 0.86 (0.73–1.01) | 0.071 |
| Group 2 (65–74) | −0.04 | 0.97 (0.80–1.17) | 0.711 |
| Group 4 (≥ 75) | −0.07 | 0.93 (0.75–1.16) | 0.536 |
ECMO = extracorporeal membrane oxygenation.
a
Group 1 (18–49 yr) referent category.